{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nFor example, the mTOR inhibitor inhibits both mTORC1 and mTORC2 with an IC50 value of about 500 nM or less, 400 nM or less, 300 nM or less, 200 nM or less, 100 nM or less, 50 nM or less, 10 nM or less, or 1 nM or less, as ascertained in an in vitro kinase assay.\nIn another embodiment, the mTOR inhibitor inhibits both mTORC1 and mTORC2 with an IC50 value of about 10 nM or less as ascertained in an in vitro kinase assay, and the mTOR inhibitor is substantially inactive against one or more types I PI3-kinases selected from the group consisting of PI3-kinase \u03b1, PI3-kinase \u03b2, PI3-kinase \u03b3, and PI3-kinase \u03b4.\nAlternatively, the mTOR inhibitor inhibits both mTORC1 and mTORC2 with an IC50 value of about 100 nM or less as ascertained in an in vitro kinase assay, and the IC50 value is at least 2, 5 or 10 times less than its IC50 value against all other type I PI3-kinases selected from the group consisting of PI3-kinase \u03b1, PI3-kinase \u03b2, PI3-kinase \u03b3, and PI3-kinase \u03b4.\nIn various embodiments, the concentration of mTOR inhibitor required to reduce mTOR enzymatic activity is less than about 1 \u03bcM, less than about 500 nM, less than about 100 nM, less than about 50 nM, or less than about 10 nM.\nIn various embodiments, the concentration of Aurora A kinase inhibitor required to reduce an Aurora A kinase enzymatic activity is less than about 1 \u03bcM, less than about 500 nM, less than about 100 nM, less than about 50 nM, or less than about 10 nM."}
{"final_json": [{"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "500 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "400 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "300 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "200 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "100 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "50 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "10 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "1 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "10 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "100 nM or less", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 1 \u03bcM", "unit": "\u03bcM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 500 nM", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 100 nM", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 50 nM", "unit": "nM"}, {"molecule_name": "mTOR inhibitor", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 10 nM", "unit": "nM"}, {"molecule_name": "Aurora A kinase inhibitor", "protein_target_name": "Aurora A kinase", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 1 \u03bcM", "unit": "\u03bcM"}, {"molecule_name": "Aurora A kinase inhibitor", "protein_target_name": "Aurora A kinase", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 500 nM", "unit": "nM"}, {"molecule_name": "Aurora A kinase inhibitor", "protein_target_name": "Aurora A kinase", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 100 nM", "unit": "nM"}, {"molecule_name": "Aurora A kinase inhibitor", "protein_target_name": "Aurora A kinase", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 50 nM", "unit": "nM"}, {"molecule_name": "Aurora A kinase inhibitor", "protein_target_name": "Aurora A kinase", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "< 10 nM", "unit": "nM"}]}
{"raw_mentions": "In some embodiments of the methods of the invention, the mTORC1/2 inhibitor inhibits both mTORC1 and mTORC2 with an IC50 value of about 500 nM or less, 400 nM or less, 300 nM or less, 200 nM or less, 100 nM or less, 50 nM or less, 10 nM or less, or 1 nM or less, as ascertained in an in vitro kinase assay.\nIn another embodiment, the mTORC1/2 inhibitor inhibits both mTORC1 and mTORC2 with an IC50 value of about 10 nM or less as ascertained in an in vitro kinase assay, and the mTORC1/2 inhibitor is substantially inactive against one or more types I PI3-kinases selected from the group consisting of PI3-kinase \u03b1, PI3-kinase \u03b2, PI3-kinase \u03b3, and PI3-kinase \u03b4.\nAlternatively, the mTORC1/2 inhibitor inhibits both mTORC1 and mTORC2 with an IC50 value of about 100 nM or less as ascertained in an in vitro kinase assay, and the IC50 value is at least 2, 5 or 10 times less than its IC50 value against all other type I PI3-kinases selected from the group consisting of PI3-kinase \u03b1, PI3-kinase \u03b2, PI3-kinase \u03b3, and PI3-kinase \u03b4."}
{"final_json": [{"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "500 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "400 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "300 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "200 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "100 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "50 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "10 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "1 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "10 nM or less", "unit": null}, {"molecule_name": "mTORC1/2 inhibitor", "protein_target_name": "mTORC1 and mTORC2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "100 nM or less", "unit": null}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, IDs, or identifiers along with bioactivity metrics, numeric values, and units. The text primarily discusses methods and calculations for analyzing drug synergy, but it does not provide specific data that includes all four required components."}
